1178
P. Bataille et al. / Tetrahedron: Asymmetry 11 (2000) 1165±1181
(s, 1H). 13C NMR (CDCl3) ꢁ: 11.36, 15.96, 22.35, 54.48, 58.98, 67.66, 72.39, 123.98, 126.24,
126.73, 126.76, 127.61, 127.79, 128.63, 132.98, 134.04, 136.14, 166.96. 19F NMR ꢁ: 70.9.
3.32. 2-Acetylfuran-N-[(1R)-1-(methoxymethyl)propyl]-N-(2,2,2-tri¯uoroethyl)hydrazone (R)-
( )-40
Starting from (R)-(+)-26 (300 mg, 1.5 mmol), 2-acetylfurane (0.1 ml, 1 mmol) and TsOH
(catalytic amount) in anhydrous toluene (20 ml), the above procedure (see Section 3.2) led to
hydrazone (R)-( )-40 as a yellow oil after chromatography (eluent: cyclohexane:ether. 9:1, then
elution gradient) (182 mg, 62.3%), [ꢀ]D 139 (c 2, MeOH). Anal. calcd for C13H19F3N2O2:
1
C, 53.42; H, 6.55; N, 9.58. Found: C, 53.94; H, 6.61; N, 9.79. IR (®lm): 1602 (CN) cm .
1H NMR (CDCl3) ꢁ: 1.01 (t, J=7.4 Hz, 3H), 1.58±1.66 (m, 2H), 2.32 (s, 3H), 2.72±2.78 (m, 1H),
3.32 (s, 3H), 3.55 (t, J=4.7 Hz, 2H), 3.63±3.70 (AB, J=9.4 Hz, 2H), 6.45 (dd, J=1.7 and 3.4 Hz,
1H), 6.77 (d, J=3.4 Hz, 1H), 7.50 (d, J=1.6 Hz, 1H). 13C NMR (CDCl3) ꢁ: 11.22, 15.06,
22.14, 54.18, 58.89, 67.80, 72.09, 111.32, 118.86, 125.38, 144.18, 152.05, 159.18. 19F NMR ꢁ:
71.1.
3.33. 3,4-Dihydro(2H)naphthalen-1-one-N-[(1R)-1-(methoxymethyl)propyl]-N-(2,2,2-tri¯uoro-
ethyl)hydrazone (R)-( )-41
Starting from (R)-(+)-26 (480 mg, 2.4 mmol), a-tetralone (234 mg, 1.6 mmol) and TsOH
(catalytic amount) in anhydrous toluene (15 ml), the above procedure (see Section 3.2) after 4
days under re¯ux, led to hydrazone (R)-( )-41 as a yellow oil after chromatography (eluent:
cyclohexane) (219 mg, 41.7%), [ꢀ]D 136 (c 0.7, MeOH). Anal. calcd for C17H23F3N2O: C, 62.18;
1
1
H, 7.06; N, 8.53. Found: C, 62.29; H, 6.84; N, 8.32. IR (®lm): 1616 (CN) cm . H NMR
(CDCl3) ꢁ: 1.01 (t, J=7.4 Hz, 3H), 1.55±1.63 (m, 2H), 1.85±1.94 (m, 2H), 2.70±2.78 (m, 2H), 2.83
(t, J=6.1 Hz, 2H), 2.94±3.00 (m, 1H), 3.33 (s, 3H), 3.50 (dd, J=4.7 and 9.6 Hz, 1H), 3.61 (dd,
J=4.7 and 9.6 Hz, 1H), 3.62±3.68 (m, 2H), 7.13 (d, J=7.7 Hz, 1H), 7.17±7.23 (m, 1H), 7.26±7.31
(td, J=1.2 and 7.4 Hz, 1H), 8.17 (d, J=7.8 Hz, 1H). 13C NMR (CDCl3) ꢁ: 11.36, 22.32, 22.48,
27.87, 29.83, 54.47, 58.94, 67.58, 72.49, 125.12, 125.33, 126.10, 128.65, 128.85, 132.80, 140.39,
166.59. 19F NMR ꢁ: 70.0.
3.34. 1-[(1R)-1-(Methoxymethyl)propyl]-1-methyl-2-(1-phenylethyl)hydrazine 42
A suspension of LiAlH4 (126 mg, 3.3 mmol) in dry ether (30 ml) was cooled to 10ꢀC and
treated dropwise by hydrazone (R)-( )-27 (54 mg, 0.22 mmol) in dry ether (10 ml). After stirring
under re¯ux for 72 h, the mixture was quenched at 10ꢀC by methanol and water. After 30 min
at room temperature, the suspension was ®ltered and the ®ltrate was evaporated under reduced
pressure. The aqueous residue was extracted three times with ether (3Â10 ml). The organic
extracts were pooled, dried (MgSO4) and evaporated under reduced pressure, thus leading to the
hydrazine 42 as a colourless and unstable oil, without further puri®cation (28 mg, 52%),
1
d.e.=43% (1H NMR). H NMR (200 MHz) (CDCl3) ꢁ major diastereomer: 0.83 (t, J=7.3 Hz,
3H), 1.10±1.60 (m, 2H), 1.29 (d, J=6.4 Hz, 3H), 2.49 (s, 3H), 2.50±2.80 (m, 1H), 3.24 (s, 3H), 3.32
(dd, J=5.5 and 10.3 Hz, 1H), 3.52 (dd, J=7.6 and 9.7 Hz, 1H), 3.94 (q, J=6.5 Hz, 1H), 7.00±7.40
(m, 5H); minor diastereomer: 0.80 (m, 3H), 1.10±1.60 (m, 5H), 2.47 (s, 3H), 2.50±2.80 (m, 1H),
3.33 (s, 3H), 3.28±3.57 (m, 2H), 3.89±3.99 (m, 1H), 7.00±7.40 (m, 5H).